Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax)

NCT03460730 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Pneumonia, Pneumococcal

Interventions

BIOLOGICAL: Pneumovax

Sponsor

KEMRI-Wellcome Trust Collaborative Research Program